{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:48:53Z","timestamp":1793137733202,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70204-w","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:21:57Z","timestamp":1772814117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment"],"prefix":"10.1038","volume":"17","author":[{"given":"Yuxuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9771-7379","authenticated-orcid":false,"given":"Siwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-5691","authenticated-orcid":false,"given":"Yinkuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xidong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-2577","authenticated-orcid":false,"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuohang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-6275","authenticated-orcid":false,"given":"Yiding","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7436-1415","authenticated-orcid":false,"given":"Ziao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-5007","authenticated-orcid":false,"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-8896","authenticated-orcid":false,"given":"Chao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"70204_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100851","volume":"3","author":"CA La Porta","year":"2022","unstructured":"La Porta, C. A. & Zapperi, S. Artificial intelligence in breast cancer diagnostics. Cell Rep. Med 3, 100851 (2022).","journal-title":"Cell Rep. Med"},{"key":"70204_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao, W., Chen, H., Yu, Y., Li, N. & Chen, W. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin. med j.-peking. 134, 783\u2013791 (2021).","journal-title":"Chin. med j.-peking."},{"key":"70204_CR3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","volume":"331","author":"USPST Force","year":"2024","unstructured":"Force, U. S. P. S. T. et al. Screening for breast cancer: US preventive services task force recomme ndation statement. JAMA 331, 1918 (2024).","journal-title":"JAMA"},{"key":"70204_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46234\/ccdcw2023.062","volume":"5","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Breast cancer screening coverage \u2014 China, 2018\u20132019. China cdc Wkly. 5, 321\u2013326 (2023).","journal-title":"China cdc Wkly."},{"key":"70204_CR5","doi-asserted-by":"crossref","unstructured":"de Abreu, A. R. et al. Circulating tumor dna detection in cancer: a comprehensive overview of current detection methods and prospects. The oncologist 30, 10.1093\/oncolo\/oyaf204 (2025).","DOI":"10.1093\/oncolo\/oyaf204"},{"key":"70204_CR6","unstructured":"Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C. & Seiden, M. V. Consortium C. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745\u2013759 (2020)."},{"key":"70204_CR7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","volume":"40","author":"A Jamshidi","year":"2022","unstructured":"Jamshidi, A. et al. Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer cell 40, 1537\u20131549.e1512 (2022).","journal-title":"Cancer cell"},{"key":"70204_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","volume":"570","author":"S Cristiano","year":"2019","unstructured":"Cristiano, S. et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385\u2013389 (2019).","journal-title":"Nature"},{"key":"70204_CR9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","volume":"43","author":"WHA Tsui","year":"2025","unstructured":"Tsui, W. H. A., Jiang, P. & Lo, Y. M. D. Cell-free DNA fragmentomics in cancer. Cancer cell 43, 1792\u20131814 (2025).","journal-title":"Cancer cell"},{"key":"70204_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12714-4","volume":"10","author":"P Ulz","year":"2019","unstructured":"Ulz, P. et al. Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nat. Commun. 10, 4666 (2019).","journal-title":"Nat. Commun."},{"key":"70204_CR11","doi-asserted-by":"publisher","first-page":"E6600","DOI":"10.1073\/pnas.1612835113","volume":"113","author":"X Fu","year":"2016","unstructured":"Fu, X. et al. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. Proc. natl. acad. sci. Usa 113, E6600\u2013E6609 (2016).","journal-title":"Proc. natl. acad. sci. Usa"},{"key":"70204_CR12","first-page":"186","volume":"14","author":"M Rampurwala","year":"2016","unstructured":"Rampurwala, M., Wisinski, K. B. & O\u2019Regan, R. Role of the androgen receptor in triple-negative breast cancer. Clin. Adv. Hematol. Oncol. 14, 186\u2013193 (2016).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"70204_CR13","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/jjco\/hyw096","volume":"46","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J. Clin. Oncol. 46, 893\u2013902 (2016).","journal-title":"Jpn J. Clin. Oncol."},{"key":"70204_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/onc.2013.64","volume":"33","author":"MF Kendellen","year":"2014","unstructured":"Kendellen, M. F., Bradford, J. W., Lawrence, C. L., Clark, K. S. & Baldwin, A. S. Canonical and non-canonical NF-kappaB signaling promotes breast cancer tumor-initiating cells. Oncogene 33, 1297\u20131305 (2014).","journal-title":"Oncogene"},{"key":"70204_CR15","doi-asserted-by":"publisher","unstructured":"Yin, Q., Zheng, M., Luo, Q., Jiang, D., Zhang, H. & Chen, C. YB-1 as an oncoprotein: Functions, regulation, post-translational modifications, and targeted therapy. Cells 11, https:\/\/doi.org\/10.1016\/j.annonc.2020.02.011 (2022).","DOI":"10.1016\/j.annonc.2020.02.011"},{"key":"70204_CR16","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1158\/0008-5472.CAN-18-0069","volume":"78","author":"W Zhang","year":"2018","unstructured":"Zhang, W. et al. Loss of Estrogen-Regulated MIR135A1 at 3p21.1 promotes tamoxifen resistance in breast cancer. Cancer Res 78, 4915\u20134928 (2018).","journal-title":"Cancer Res"},{"key":"70204_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","volume":"10","author":"J Masliah-Planchon","year":"2015","unstructured":"Masliah-Planchon, J., Bieche, I., Guinebretiere, J. M., Bourdeaut, F. & Delattre, O. SWI\/SNF chromatin remodeling and human malignancies. Annu Rev. Pathol. 10, 145\u2013171 (2015).","journal-title":"Annu Rev. Pathol."},{"key":"70204_CR18","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3892\/mmr.2017.7071","volume":"16","author":"C Li","year":"2017","unstructured":"Li, C., Wang, Z., Tang, X., Zeng, L., Fan, X. & Li, Z. Molecular mechanisms and potential prognostic effects of REST and REST4 in glioma (Review). Mol. Med Rep. 16, 3707\u20133712 (2017).","journal-title":"Mol. Med Rep."},{"key":"70204_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41388-025-03284-5","volume":"44","author":"KF Man","year":"2025","unstructured":"Man, K. F. et al. CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance. Oncogene 44, 1093\u20131105 (2025).","journal-title":"Oncogene"},{"key":"70204_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27734-2","volume":"13","author":"XZ Liu","year":"2022","unstructured":"Liu, X. Z. et al. C\/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer. Nat. Commun. 13, 69 (2022).","journal-title":"Nat. Commun."},{"key":"70204_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj9283","volume":"16","author":"AV Annapragada","year":"2024","unstructured":"Annapragada, A. V. et al. Genome-wide repeat landscapes in cancer and cell-free DNA. Sci. Transl. Med 16, eadj9283 (2024).","journal-title":"Sci. Transl. Med"},{"key":"70204_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35959-6","volume":"14","author":"Y An","year":"2023","unstructured":"An, Y. et al. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation. Nat. Commun. 14, 287 (2023).","journal-title":"Nat. Commun."},{"key":"70204_CR23","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1158\/0008-5472.CAN-23-3486","volume":"84","author":"Y Cao","year":"2024","unstructured":"Cao, Y. et al. Multidimensional fragmentomics enables early and accurate detection of colorectal cancer. Cancer Res 84, 3286\u20133295 (2024).","journal-title":"Cancer Res"},{"key":"70204_CR24","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1158\/0008-5472.CAN-24-1517","volume":"85","author":"TR Lee","year":"2025","unstructured":"Lee, T. R. et al. Integrating Plasma cell-free DNA fragment end motif and size with genomic features enables lung cancer detection. Cancer Res 85, 1696\u20131707 (2025).","journal-title":"Cancer Res"},{"key":"70204_CR25","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl, S., Poortmans, P., Morrow, M., Denkert, C. & Curigliano, G. Breast cancer.  Lancet 397, 1750\u20131769 (2021).","journal-title":"Lancet"},{"key":"70204_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00252-6","volume":"7","author":"T Grinda","year":"2021","unstructured":"Grinda, T. et al. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort. npj Breast Cancer 7, 41 (2021).","journal-title":"npj Breast Cancer"},{"key":"70204_CR27","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","volume":"31","author":"F Cardoso","year":"2020","unstructured":"Cardoso, F. et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann. Oncol. 31, 1623\u20131649 (2020).","journal-title":"Ann. Oncol."},{"key":"70204_CR28","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3390\/cancers15102664","volume":"15","author":"Y Hou","year":"2023","unstructured":"Hou, Y., Nitta, H. & Li, Z. HER2 intratumoral heterogeneity in breast cancer, an evolving concept. Cancers 15, 2664 (2023).","journal-title":"Cancers"},{"key":"70204_CR29","doi-asserted-by":"crossref","unstructured":"Morawitz, J. et al. Determining the axillary nodal status with 4 current imaging modalities, including 18F-FDG PET\/MRI, in newly diagnosed breast cancer: a comparative study using histopathology as the reference standard. J. Nucl. Med. 62, 1677\u20131683 (2021).","DOI":"10.2967\/jnumed.121.262009"},{"key":"70204_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/2326-6066.CIR-15-0214","volume":"4","author":"Y Kurebayashi","year":"2016","unstructured":"Kurebayashi, Y. et al. Comprehensive immune profiling of lung adenocarcinomas reveals four immunosubtypes with plasma cell subtype a negative indicator. Cancer Immunol. Res 4, 234\u2013247 (2016).","journal-title":"Cancer Immunol. Res"},{"key":"70204_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"70204_CR32","volume":"1878","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Ouyang, Y., Li, Z., Wang, X. & Ma, J. S100A8 and S100A9 in Cancer. Bba-rev. Cancer 1878, 188891 (2023).","journal-title":"Bba-rev. Cancer"},{"key":"70204_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06230-z","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis. 14, 703 (2023).","journal-title":"Cell Death Dis."},{"key":"70204_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41392-018-0013-x","volume":"3","author":"M Hiraki","year":"2018","unstructured":"Hiraki, M. et al. Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer. Signal Transduct. Target Ther. 3, 13 (2018).","journal-title":"Signal Transduct. Target Ther."},{"key":"70204_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","volume":"8","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct. Target Ther. 8, 97 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"70204_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239732","volume":"14","author":"CL Wolf","year":"2023","unstructured":"Wolf, C. L., Pruett, C., Lighter, D. & Jorcyk, C. L. The clinical relevance of OSM in inflammatory diseases: a comprehensive review. Front Immunol. 14, 1239732 (2023).","journal-title":"Front Immunol."},{"key":"70204_CR37","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2025.02.007","volume":"58","author":"C Luo","year":"2025","unstructured":"Luo, C. et al. Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells. Immunity 58, 745\u2013765.e749 (2025).","journal-title":"Immunity"},{"key":"70204_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-024-03408-6","volume":"31","author":"N Eisemann","year":"2025","unstructured":"Eisemann, N. et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nat. Med 31, 917\u2013924 (2025).","journal-title":"Nat. Med"},{"key":"70204_CR39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1470-2045(23)00298-X","volume":"24","author":"K L\u00e5ng","year":"2023","unstructured":"L\u00e5ng, K. et al. Artificial intelligence-supported screen reading versus standard double reading in the mammography screening with artificial intelligence trial (MASAI): A clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lancet Oncol. 24, 936\u2013944 (2023).","journal-title":"Lancet Oncol."},{"key":"70204_CR40","doi-asserted-by":"publisher","unstructured":"Pons-Belda, O. D., Fern\u00e1ndez-Uriarte, A. & Diamandis, E. P. Can circulating tumor DNA support a successful screening test for early cancer detection? The grail paradigm. diagnostics (Basel) 11, https:\/\/doi.org\/10.3390\/diagnostics11122171 (2021).","DOI":"10.3390\/diagnostics11122171"},{"key":"70204_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40611-w","volume":"13","author":"HJ Kwon","year":"2023","unstructured":"Kwon, H. J. et al. Advances in methylation analysis of liquid biopsy in early cancer detection of colorectal and lung cancer. Sci. Rep. 13, 13502 (2023).","journal-title":"Sci. Rep."},{"key":"70204_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.32308","volume":"76","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics. Hepatology 76, 317\u2013329 (2022).","journal-title":"Hepatology"},{"key":"70204_CR43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1164\/rccm.202109-2019OC","volume":"207","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Multidimensional Cell-Free DNA fragmentomic assay for detection of early-stage lung cancer. Am. J. Respir. crit. care med 207, 1203\u20131213 (2023).","journal-title":"Am. J. Respir. crit. care med"},{"key":"70204_CR44","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini, O. D. et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: The SOUND randomized clinical trial. JAMA Oncol. 9, 1557 (2023).","journal-title":"JAMA Oncol."},{"key":"70204_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101756","volume":"55","author":"T Reimer","year":"2023","unstructured":"Reimer, T. et al. Patient-reported outcomes for the intergroup sentinel mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer. eClinicalMedicine 55, 101756 (2023).","journal-title":"eClinicalMedicine"},{"key":"70204_CR46","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Abstract PS1-30: A prospective phase II trial to evaluate the feasibility of omitting sentinel lymph node biopsy after integrating 18F-FDG dedicated axillary PET in early breast cancer: SOAPET trial. Cancer Res 81, PS1-30\u2013PS31-30 (2021).","DOI":"10.1158\/1538-7445.SABCS20-PS1-30"},{"key":"70204_CR47","doi-asserted-by":"publisher","first-page":"175883592311781","DOI":"10.1177\/17588359231178125","volume":"15","author":"DJ Slamon","year":"2023","unstructured":"Slamon, D. J. et al. Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+\/HER2\u2212 early breast cancer. Ther. ADV med oncol. 15, 17588359231178125 (2023).","journal-title":"Ther. ADV med oncol."},{"key":"70204_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109468","volume":"135","author":"F Riedel","year":"2021","unstructured":"Riedel, F. et al. Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients. Eur. J. Radio. 135, 109468 (2021).","journal-title":"Eur. J. Radio."},{"key":"70204_CR49","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/cancers14040950","volume":"14","author":"J Cheng","year":"2022","unstructured":"Cheng, J. et al. Development of high-resolution dedicated pet-based radiomics machine learning model to predict axillary lymph node status in early-stage breast cancer. Cancers 14, 950 (2022).","journal-title":"Cancers"},{"key":"70204_CR50","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1158\/1538-7445.AM2022-5162","volume":"82","author":"Z Lin","year":"2022","unstructured":"Lin, Z. et al. Abstract 5162: TuFEst: a sensitive and cost-effective pan-cancer detection approach with accurate tumor fraction estimation. Cancer Res 82, 5162\u20135162 (2022).","journal-title":"Cancer Res"},{"key":"70204_CR51","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"70204_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"70204_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. commun. 4, 2612 (2013).","journal-title":"Nat. commun."},{"key":"70204_CR54","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb.) 2, 100141 (2021).","journal-title":"Innov. (Camb.)"},{"key":"70204_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinf 14, 7 (2013).","journal-title":"BMC Bioinf"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70204-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:02:13Z","timestamp":1772820133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70204-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70204"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70204-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6866836\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.L., W.X., and W.L. report personal fees from OmixScience Co., Ltd. during the conduct of the study and are listed as inventors on a patent application: Method and device for judging benign or malignant cancer through DNN(CN202410538100.3) related to this work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2276"}}